Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Comparing weekly and monthly auto buys for Dividend Aristocrats ETF reveals tradeoffs in cost, convenience, and growth potential. Pick the cadence that fits your plan.
16,949 articlesA biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Two popular small-cap ETFs, VB and SCHA, offer low-cost access to dynamic U.S. stocks. This guide breaks down scha: w...
Bitcoin faces a fresh warning from Wikipedia founder Jimmy Wales that BTC could drift toward lower levels, testing bu...
XRP trimmed gains after a brief rise above $1.60, but fresh ETF inflows and renewed whale buying point to near-term u...
XRP sits in a tight range around $1.40 as analysts map the path to a potential break all-time high this year. The out...
AI-driven analysis explores XRP's possible path to higher prices if Ripple secures a Fed master account. The piece ou...
XCEM has risen 38% year-to-date, beating the S&P 500 by a wide margin as investors tilt toward emerging markets ex-Ch...
Bitcoin slips under the $64,000 level as large investors step in, signaling renewed demand despite a cautious market ...
The spotlight in AI investing is shifting from screens to factories. The BOTZ ETF is positioning itself to ride a wav...
Three AI-powered models weigh two extreme BTC futures for 2026: a downturn to $30,000 or a rally to $100,000. The art...
As copper prices rise and mining profits surge, retirees are increasingly flocking to copper-focused ETFs and miners ...
Considering international real estate for income? This article breaks down HAUZ and VNQ, showing how they differ, wha...